9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Changes in Board, Management or Compensation
Earnings Release
News, Articles of Incorporation
Other Events
Shareholder votes
Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6, Investor Presentation
Investor Presentation
Q2
Q1
FY 2024
Q3
FY 2023
Effectiveness Notice
Prospectus Filed Pursuant to Rule 424(b)(2)
Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Amended Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload